NDC 24979-703
Dexlansoprazole delayed release
Dexlansoprazole
Dexlansoprazole delayed release is a Oral Capsule, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Twi Pharmaceuticals, Inc.. The primary component is Dexlansoprazole.
| Product ID | 24979-703_14535d19-cc1d-4a41-96f1-cc5ff1660029 |
| NDC | 24979-703 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dexlansoprazole delayed release |
| Generic Name | Dexlansoprazole |
| Dosage Form | Capsule, Delayed Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-01-01 |
| Marketing Category | NDA AUTHORIZED GENERIC / |
| Application Number | NDA022287 |
| Labeler Name | TWI PHARMACEUTICALS, INC. |
| Substance Name | DEXLANSOPRAZOLE |
| Active Ingredient Strength | 30 mg/1 |
| Pharm Classes | Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |